While Cote concedes “there are good options” to help patients with HMB, Channel MedSystems’ “removes the risk of anesthesia or even conscious sedation.” This means the less-than-five-minute procedure ...

Baxter International Inc. BAX recently showcased THERANOVA, a new class of medium cut-off (MCO) dialysers at the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) ...

Baxter’s HDx therapy enabled by THERANOVA was designed to filter a wider range of molecules from the blood than conventional hemodialysis filters, including mid-sized molecular weight uremic toxins ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leader in developing technologies that transform renal care, today announced the global launch of HDx enabled by THERANOVA, a ...

Baxter International Inc. BAX recently announced favorable data from the “Effectiveness of medium cut-off versus high flux dialyzers: An inverse probability weighting cohort study”. The data ...

Baxter International Inc. BAX recently announced that its novel dialysis membrane, Theranova has been granted the FDA De Novo application. Notably, Theranova was developed to deliver expanded ...

Baxter International Inc. has scored a win from the U.S. FDA, which has granted the de novo application for Theranova, the company’s novel dialysis membrane. For his part, Cowen’s Josh Jennings noted ...

TheraNova is a San Francisco-based sandbox incubator and capital technology developer for medical devices. With one exception, all the ideas for technology are internally generated, CEO Dr. Daniel ...

Baxter International Inc.BAX recently showcased THERANOVA, a new class of medium cut-off (MCO) dialysers at the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA) ...

Baxter International Inc. BAX recently announced favorable data from the “Effectiveness of medium cut-off versus high flux dialyzers: An inverse probability weighting cohort study”. The data ...